Contact Us
(888) 875-0799
(888) 875-0799
Our lead generation services help biotech and biopharma companies to reach research leads, procurement managers, and healthcare decision makers who need innovative biotechnology solutions with targeted outreach and qualified appointment setting.
Excellent 4.8 out of 5.0 on
Trustpilot
Trusted By
2100+ Businesses
BOOK YOUR CALL WITH CALLINGAGENCY
Get first qualified appointments within the first week.
Exclusive & non-shared biotech sales leads only for your company.
Schedule appointments with biotech and pharmaceutical decision makers.
Research and procurement leaders are difficult to reach due to gatekeepers, limited contact data, and lab commitment and conference schedules.
Complex healthcare procurement processes involve vendor qualification, approvals, compliance, and risk assessments, making the process complex.
Purchasing decisions depend on multiple stakeholders, such as R&D, regulatory, procurement team & clinical, all with different priorities.
Sales cycles stay long due to regulatory reviews, funding approvals, multi-stakeholder decision-making, and rigorous product evaluation processes.
Strict FDA, EMA, and GxP rules make it harder for biotech companies to attract and win new customers.
Inconsistent inbound leads from poorly targeted marketing limit new opportunities for biotech companies due to niche targeting, long sales cycles, and limited inbound demand.
Prospecting and lead generation can be difficult for biotech & biopharma companies. Our outbound lead generation and appointment setting service helps biotech companies book qualified meetings with biotech decision-makers, so their teams can focus on closing more deals.
We build qualified prospect lists of companies & biotech firms that focus on drug discovery, clinical trials, biologics manufacturing, regulatory compliance, clinical research support tools, and technologies in different therapeutic areas for targeted biotech lead generation.
We identify biopharma decision-makers such as biotech executives, research leaders, clinical trial managers, laboratory managers, and procurement managers responsible for clinical trials, laboratory services, biopharma manufacturing initiatives, and vendor selection.
Our cold calling & email campaigns are one of the most effective outreach strategies to generate leads for biotech companies. Technology-driven and solution-centric cold calling scripts and personalized email outreach help biotech companies generate high-quality leads.
We identify and connect with qualified biotech decision-makers on LinkedIn using InMail and LinkedIn Sales Navigator. Then we engage them through personalized messaging and follow-ups to generate new biotechnology sales leads
We help biotech & biopharma companies book appointments with high-intent and pre-qualified biotech decision-makers. Each lead is pre-screened for organization type, therapeutic relevance, decision-making role, evaluation intent, funding alignment, and readiness for engagement.
We integrate outreach activities, lead statuses, and appointment information into your CRM system. You receive complete campaign performance reports, including conversion rates, business information, performance data, buying signals, and activity logs.
Our 5-step C.A.L.L.S.™ framework helps turn cold prospects into qualified leads and book appointments.
Calibrate — Precision Targeting
We build prospect maps, not basic lists, because 30% of campaign success is decided before the first call.
We define your ideal customer profile using firmographic, technographic, and behavioral data, then build a verified prospect map around it. Our calibration process strips out roughly 40% of raw contacts, so your SDRs spend time only on prospects who match the profile your real buyers fit.
30%
Strategy
Arrange — Offer & Messaging
We write custom scripts, not fixed templates, because 20% of results depend on your offer and positioning.
We write outreach scripts mapped to your buyer’s real pain points. This includes cold call openers, email sequences under 125 words, and LinkedIn messages that earn replies. Every campaign launches with 3 to 5 variants we A/B test in the first two weeks to lock in your highest-converting message.
20%
Messaging
Launch — Omnichannel Outreach
Three channels working as one system, because 25% of results come from synchronized execution.
Launch is when outreach goes live. Our trained SDRs run cold calls, personalized emails, and LinkedIn prospecting as a single coordinated cadence, not three separate efforts. You stay visible in every channel your prospects trust, with 6 to 10 touchpoints over two to three weeks.
25%
Execution
Land — Qualification & Intent
Only qualified decision-makers reach your calendar, because 15% of results come from strong qualification.
Every interested lead runs through our 3-Layer Qualification Engine™. We confirm authority, validate need and budget, and lock in a defined timeline before any meeting is booked, so your closers spend their time talking to real buyers, not chasing tire-kickers.
15%
Qualification
Schedule — Booking & Reporting
Meetings booked, metrics delivered. Systems contribute 10% of results and 100% of pipeline visibility.
Qualified meetings land directly on your calendar with full call notes, prospect context, and buying signals attached. You see transparent reporting on every dial, email, and booked meeting. Most campaigns launch within 10 days, with first qualified meetings often booked inside the first week.
10%
Delivery
Many pharmaceutical companies, biotech firms, research laboratories, and healthcare organizations require biotechnology solutions for research, innovation, and medical advancement.
Our outbound lead generation books qualified meetings with research leaders, biotech executives, and pharmaceutical decision-makers seeking new technologies.
We help to speed up early-stage conversations through connecting biotech innovators with qualified organizations’ needs, clinical solutions, and strategic partnerships.
We reach pharmaceutical companies, research labs, and biotech firms seeking new platforms, technologies, or partnership opportunities.
Connect the right decision makers who manage R&D collaborations, technology adaptations, and clinical program investments.
Real samples from our campaigns
You see everything we send. Review the real call scripts, email copy, and LinkedIn messages we use to book meetings for biotech and biopharma companies.
4 min 24 sec – Meeting scheduled
Meeting booked
3 min 26 sec – Appointment booked
Qualified lead
“… How would you rate your current cleaners on a scale of 1 to 10? — Well, they started out pretty good, and they’ve kind of steadily declined.”
Cold outreach
Hi {{FirstName}},
Most {{industry}} owners I talk to in {{city}} are overpaying 0.4-0.9% on card processing without realizing it — usually buried as “non-qualified downgrades,” PCI fees, or batch fees in the fine print.
Would you be open to me pulling apart your last statement and showing you exactly where the leaks are? No switch required, no pitch. If there’s nothing to save, I’ll tell you.
Worth 10 minutes?
{{YourName}}
{{Company}} | {{Phone}}
Follow-up #2
To: Dr. Sanjay Iyer, Principal Investigator, BNC
Subject: Re:brookline’s CAR-T paper
Hey {{FirstName}} — bumping this up.
I just ran an audit for a {{similar business type}} down the road and found $347/month in fees they didn’t know they were paying. Took me about 8 minutes to spot.
If you can forward your most recent processing statement, I can do the same for you by Friday. No obligation.
{{YourName}}
Connection request note
Principal Investigator, Brookline Neuroscience Lab
Hi Dr. {{LastName}}, I work with translational research labs in {{state/region}} on flow cytometry assays for CAR-T and immuno-oncology work. No pitch. Just like staying close to what PIs your size are running into on gating issues, false positives, and antibody panels that almost work. Happy to connect.
Character count: 192 / 300
DM – (24 hrs after accept)
Principal Investigator, Brookline Neuroscience Lab
Thanks for connecting, Dr. {{LastName}}.
Saw your team’s recent paper on CAR-T persistence — solid work, especially the 21-day cytokine profile.
Most labs running that protocol lose 15-20% of samples to flow cytometry false positives at the IFN-γ gate. We built an assay that resolves the gating issue without changing your antibody panel.
Want me to send the validation packet? No demo, no rep visit.
Want to see how this performs for your business?
Challenge
Difficulty connecting with qualified decision-makers due to gatekeepers, outdated data, or poor targeting strategies.
Outcome
Direct access to high-intent prospects who have authority and interest in purchasing services.
281 Appointments
Appointments in 14 Months
“Had a great experience with the lead generation & appointment setting services. The team was punctual, professional, and really knew how to target the right leads.”
Amanda
NuBody Equipment Sales Ltd.
Challenge
Generic messaging fails to capture attention, leading to poor replies and missed appointment opportunities.
Outcome
Personalized LinkedIn outreach, email marketing, and cold calling campaigns increase engagement and improve response rates.
54 Appointments
48 meetings booked within just 4 months
“Started with a one-month trial. The first batch of appointments was good enough that we extended three more times before we just put them on a contract.”
Lisa Manzie
Stratus Building Solutions
Challenge
Sales teams waste time on meetings with prospects who lack budget, authority, or real need.
Outcome
Fully qualified appointments with prospects that meet ideal customer profile and have genuine buying intent.
373 Appointments
Appointments booked within 5 months
“I rarely write reviews, but after working with James, I felt compelled to share my experience. As a B2B company, consistent, high-quality leads are the backbone of our growth and that’s exactly what they delivered. Last month they booked 48 qualified appointments for us.”
Chad Sucato
US Card Solutions
Biotech and pharmaceutical companies choose CallingAgency for high-quality biotech and biopharma sales leads and appointments with the right decision makers.
We deliver high-quality, qualified biotech and biopharma leads from organizations engaged in drug discovery, clinical trials, and biologics development through targeted lead generation campaigns.
Building targeted B2B prospect lists at scale based on therapy area, organization type, research stage, and purchasing roles.
We deliver a stable pipeline of qualified biotech prospects by identifying organizations with active research needs, funding alignment, and technology adaptation readiness.
We connect you with the biotech decision-makers, including research leaders, biotech executives, clinical trial managers, and laboratory managers.
Combining LinkedIn prospecting, email marketing, and cold calling to reach biotech decision-makers through personalized outreach that drives higher response rates and qualified appointments.
Our targeted multichannel outreach identifies biotech decision-makers and books qualified meetings within the first week, while other companies take 6-8 weeks.
Each appointment we book comes with confirmed scheduling, verified biotech decision-maker details, and CRM-ready reporting.
Let’s get qualified appointments on your calendar today. Schedule a free consultation and see how we generate real results—fast.
Scheduling a meeting with decision-makers who manage clinical trials, laboratory services, biopharma manufacturing initiatives, and vendor selection for biotech and biopharma solutions, and who are open to discussing relevant solutions with decision-making authority, qualifies a booked appointment.
We target decision makers like research leaders, clinical trial managers, laboratory managers, and procurement managers with targeted biopharma lead generation campaigns.
Our lead generation experts specifically target organizations such as hospitals and healthcare systems, academic research institutions, pharmaceutical companies, biotechnology research firms, and more.
Most biotech and biopharma companies start receiving qualified appointments within the first week, while many agencies take 6–8 weeks.
Yes, we build biotech prospect lists according to your ideal organization profile, focusing on criteria such as pipeline stage, therapeutic area, industry segment, regulatory stage, and location, and include relevant decision-makers within those organizations. So you don't need to provide them.
We use omnichannel outreach methods such as LinkedIn prospecting, email marketing and cold calling to connect and engage biotech decision makers responsible for budgeting and vendor selection decisions.
Yes, we target specific biotech research fields, focusing on organization types such as biotech startups and research institutions with therapeutic areas, biologics, cell and gene therapy, preclinical and clinical stages, and pipeline maturity.
We schedule appointments directly on your calendar with qualified biotech prospects or we can also send meeting details for manual scheduling.
We deliver transparent campaign reports including campaign reports, including lead statuses, outreach activity, email sent, total calls made, appointments booked, campaign performance, conversion summaries, and notes.
Service Request